Key result
Heparin-induced thrombocytopenia occurs in ~8% of ECMO patients, but platelet trends fail to guide testing.
Cohort (n=96)
No
Answers are grounded in this paper and cite their sources.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Sokolovic et al. (2016) conducted a cohort in Extracorporeal membrane oxygenator (ECMO) patients (n=96). Extracorporeal membrane oxygenation (ECMO) was evaluated on Prevalence of heparin-induced thrombocytopenia. Among ECMO patients surviving >48 hours, the prevalence of heparin-induced thrombocytopenia was 8.3%, and platelet count trends did not significantly differ to guide testing decisions.
Synapse has enriched 10 related papers. Consider them for comparative context: